ILC Therapeutics Limited – Trademark Portfolio

Entity Type: 99

ILC Therapeutics Limited holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include ALFACYTE and CANIFERON.

Biocity Scotland, Bo'ness Road

Motherwell, Lanarkshire ML1 5UH

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CANIFERON
CANIFERON
Registered 2021
ALFACYTE
ALFACYTE
Registered 2021

Trademark Classifications

ILC Therapeutics Limited's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does ILC Therapeutics Limited have?

ILC Therapeutics Limited has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does ILC Therapeutics Limited file in?

ILC Therapeutics Limited files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ILC Therapeutics Limited's most well-known trademarks?

ILC Therapeutics Limited's registered trademark portfolio includes well-known marks such as ALFACYTE and CANIFERON. These are among 2 currently registered trademarks in the portfolio.

What is ILC Therapeutics Limited's trademark registration success rate?

ILC Therapeutics Limited has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.